Novartis CEO: Reality of Trump’s drug pricing to set in over next 18 months
Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult…
Roche Obesity Shot Led to 18% Weight Loss in Study
Roche Holding AG said patients on its experimental shot lost 18% more weight than those who got placebo…
Novartis shells out $2 billion for immunology biotech Excellergy
A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus…
Roche Breast-Cancer Drug Combination Misses Target in Study
Roche Holding AG’s experimental breast-cancer pill failed to meet the main goal of a study, a blow to…
Roche to invest ₩710B in South Korea over five years
Roche Holding AG pledged to invest ₩710 billion (US$484.6 million) in South Korea over the next five years,…
Roche shares drop after oral breast cancer drug trial
Sopa Images | Lightrocket | Getty Images Roche’s shares dropped more than 5% on Monday as the Swiss…
Roche’s Potential Blockbuster Fuels Best Month Since 1997
Roche Holding AG’s shares just posted their best month since 1997, lifted by optimism over an experimental breast…
Roche to invest ₩710B in South Korea over five years
Roche Holding AG pledged to invest ₩710 billion (US$484.6 million) in South Korea over the next five years,…
Novartis, Roche Near US Drug Price Deal as White House Prepares Announcement
The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding…
Roche joins race for obesity drugs with $2.7 billion Carmot deal
A photo showing the logo of Swiss pharmaceutical giant Roche in Basel. SEBASTIEN BOZON | AFP | Getty…
Bispecific Antibodies Market – Global Forecast 2025-2032, Profiles of Key Players
Company Logo The bispecific antibodies market presents key opportunities in oncology, autoimmune, and infectious diseases, driven by rapid…
Novartis, Roche could be most at risk
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer…